Safety study of IMP761 in healthy volunteers
This is a first-in-human study testing the safety of an experimental drug called IMP761. It is an antibody that may affect the immune system. Healthy volunteers aged 18 to 55 can participate to help researchers learn about the drug's safety and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old and in good health.
- Your body mass index (BMI) is between 18 and 32, and you weigh at least 50 kg (110 pounds).
- You are willing to use effective contraception if you are of childbearing potential or are a male having sex with a woman who could become pregnant.
- You have not used any prescription or over-the-counter medications (except acetaminophen) in the last 21 days.
- You are not currently taking any medications that affect your immune system and have not used them in the past 30 days.
- You have no significant skin conditions (like eczema) where the drug might be applied, and no tattoos in that area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.
This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.
This trial tests a new medicine called BCD-261 in healthy men to see if it is safe and how the body processes it. Participants will receive increasing doses and be monitored for about 4 months.
This trial is testing a new study drug called LAD106 to see if it is safe in healthy adults. It helps researchers learn how the drug works in the body before moving on to patients with a specific condition.
This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.